NEW YORK STOCK EXCHANGE, INC. · BMY

-1.86% · -$1.07 · Vol 2.6M

Live · updated 10:38:19 ET

Bristol-Myers Squibb Co

Pharmaceuticals

$56.51

Card

Relationship Map

Follow $BMY

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $BMY by email

Veridion Score

BETAHIGH CONF · 6 of 6 factors measured

Mon Oct 12 · last completed session · daily score · 18h old · BMY

Methodology

BMY

Bristol-Myers Squibb Co

Mon Oct 12 · last completed session · daily score · 18h old

77/100

Highest qualified

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

77/ 100

Veridion Score

Highest qualified · HIGH confidence · 6 of 6 factors measured

Sovereign · $25/mo

See why this score moved.

· Factor breakdown with raw signals
· Day-over-day delta + driver
· Factor coverage readout
· Valuation · hype · market flow
· Pro Chart event markers
· Score history + alerts

Start Sovereign · $25/mo →or $250/yr

Cancel anytime · or Reserve · $79/mo or $790/yr

Confidence: HIGH · 6 of 6 factors measured · Mon Oct 12 · last completed session · daily score · 18h old

Share on X →

AI Analysis

Sovereign

Why is BMY moving today?

Sovereign unlock connects news, insider activity, analyst moves, and available price action.

Catalyst calendar

What can move BMY next.

Earnings, ratings, disclosures, volume, and score-history events. Every row needs a dated receipt.

Congress / Form 4 / Score

Upcoming

No dated upcoming catalyst is present in the current source window.

Recent

Oct 12
Score
Score moved +7
70/Upper range -> 77/Highest qualified
Veridion score historySource
Sep 10
Form 4
Massacesi Cristian Form 4 sale
SEC Form 4
Aug 26
Form 4
Holzer Phil M Form 4 sale
SEC Form 4
May 7
Congress
Mike Kelly sale disclosed
STOCK Act filing
Mar 27
Congress
Alan Armstrong purchase disclosed
STOCK Act filing
Dec 19
Congress
Gilbert Ray Cisneros, Jr. purchase disclosed
STOCK Act filing
Dec 18
Congress
Julie Johnson sale disclosed
STOCK Act filing
Nov 13
Congress
Julie Johnson sale disclosed
STOCK Act filing
Nov 12
Congress
Gilbert Ray Cisneros, Jr. purchase disclosed
STOCK Act filing
Oct 9
Congress
Gilbert Ray Cisneros, Jr. sale disclosed
STOCK Act filing

About Bristol-Myers Squibb Co

PHARMACEUTICAL PREPARATIONS

Listed since

1952

Employees

33K

Country

Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

Company website →

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open

$57.77

Day high

$58.02

Day low

$56.15

Previous close

$57.58

52W high

$68.09

-17.01% from high

52W low

$42.60

55% of range

Market cap

$117.6B

P/E

12.62×

EPS

$4.54

Beta

0.04

Shares out

Volume

2.6M

0.22× rel vol

Avg volume

12M

VWAP

$56.68

Price history computed in-house

-5.17%

-11.20%

-3.76%

+29.79%

YTD

+4.76%

SMA 50 $63.96 · below

SMA 200 $59.55 · below

52W position 55%

BMY overview

Veridion Score

Registered · 2026-10-12

6 of 6 factors measured

Latest receipt rows

Gilbert Ray Cisneros, Jr. · Purchase

13F holders

None on file

Relationship mapTrace receipt-backed holders and filings around BMY.Congress disclosuresOpen receipt and filing context for BMY.MethodologyReview score inputs, coverage rules, and limitations.

SEC Form 4 ledger

BMY insider activity

Bristol-Myers Squibb Co

90 days, by filing date. This issuer checked through Oct 12, 2026, 4:25 PM EDT. Published Oct 12, 2026, 4:32 PM EDT.

Score

77 · Highest qualified

Pressure

Net selling

Transactions

Filings

Buys / sells

0 / 2

Net value

-$437K

Insiders

Named filers

Massacesi Cristian

EVP,Chief Med Offr,Head of Dev

Officer

Holzer Phil M

SVP and Controller

Officer

Cluster

No multi-insider purchase cluster in this filing window

Net pressure

Net selling: -$437K across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Showing 2 of 2 rows.

Scroll across filed transactions. Filing date stays visible.

Filing date	Trade date	Insider	Title	Type	Price	Qty	Owned	Value	Receipt
2026-09-10	2026-09-09	Massacesi Cristian	EVP,Chief Med Offr,Head of Dev	sell	$64.57	6,249	18,748	$403K	SEC Form 4
2026-08-26	2026-08-25	Holzer Phil M	SVP and Controller	sell	$67.50	500	16,862	$34K	SEC Form 4

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology

Public disclosures

Congress activity in BMY

Congress tracker Open ticker disclosure ledger →

36 filers · 45 buys · 69 sells (6 labeled S (partial)) · 1 other · Feb 5, 2014 to May 7, 2026 · House 89 / Senate 26

All available history · Latest 5 of 115 lines · Read Oct 13, 2026, 2:38 PM UTC

Gilbert Ray Cisneros, Jr.Buy

Bristol-Myers Squibb Company Common Stock · Transaction Dec 19, 2025 · Filed Jan 12, 2026 · $1,001 to $15,000

Official filing ↗

Julie JohnsonSelljoint

Bristol-Myers Squibb Company Common Stock · Transaction Dec 18, 2025 · Filed Jan 15, 2026 · $1,001 to $15,000

Official filing ↗

Julie JohnsonSelljoint

Bristol-Myers Squibb Company Common Stock · Transaction Nov 13, 2025 · Filed Dec 11, 2025 · $1,001 to $15,000

Official filing ↗

Gilbert Ray Cisneros, Jr.Buy

Bristol-Myers Squibb Company Common Stock · Transaction Nov 12, 2025 · Filed Dec 15, 2025 · $1,001 to $15,000

Official filing ↗

Gilbert Ray Cisneros, Jr.Sell

Bristol-Myers Squibb Company Common Stock · Transaction Oct 9, 2025 · Filed Nov 18, 2025 · $1,001 to $15,000

Official filing ↗

See all 115 trades, filters and CSV — Sovereign $25/mo

Federal contracts

BMY contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed

Refresh interval: 12hSource: Federal contract awards

No federal contracts on file for BMY in this window.

Lobbying spend

BMY lobbying filings, year to date.

Registered lobbying filings matched to Bristol-Myers Squibb Co.

$5.9M

Refresh interval: 12hSource: LDA disclosure filings

Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Copyright/Patent/Trademark Trade (domestic/foreign)Health Issues Medicare/MedicaidHealth Issues Medicare/Medicaid Trade (domestic/foreign) Pharmacy

Filing

$3.2M

BRISTOL-MYERS SQUIBB COMPANY

Jul 20, 2026

Filing

$1.3M

BRISTOL-MYERS SQUIBB COMPANY

Apr 20, 2026

Filing

$1.3M

BRISTOL-MYERS SQUIBB COMPANY

Jan 20, 2026